Bio-Rad Laboratories Inc is a global leader in life science research and clinical diagnostics. The company's mission is to advance scientific discovery and improve healthcare through innovative products and technologies. Bio-Rad's strategy focuses on expanding its portfolio in key areas such as genomics, proteomics, and diagnostics, while fostering collaboration with researchers and healthcare professionals. With a commitment to quality and customer satisfaction, Bio-Rad operates through two main segments: Life Science and Clinical Diagnostics, providing essential tools and solutions that empower scientists and clinicians to make significant advancements in their fields.

BIO-RAD LABORATORIES INC

Bio-Rad Laboratories (BIO) continues to showcase its strength in the market, reporting impressive financial results for the third quarter of 2024. The company achieved an adjusted earnings per share (EPS) of $2.01, which not only surpasses the Zacks Consensus Estimate by a remarkable 57% but also reflects its robust operational...

Bio-Rad Laboratories Reports Strong Q3 2024 Earnings, Exceeding Estimates with Adjusted EPS of $2.01 and Revenue of $649.7 Million

Bio-Rad Laboratories has reported a remarkable Q3 2024, with adjusted EPS of $2.01 and revenues of $649.7 million, both exceeding estimates significantly. As the company continues to outperform its peers, can it maintain this momentum in a competitive medical landscape?